Clinical Trial

Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL

Name: Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL — clinical trial record (NCT07203352)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This prospective, randomized, controlled trial evaluates the efficacy and safety of a new targeted drug combined with chemotherapy versus standard chemotherapy alone. Eligible patients were randomized 1:1 to either the treatment or control group.

Trial Details

NCT Number	NCT07203352
Lead Sponsor	Nanfang Hospital, Southern Medical University
Conditions	Acute Lymphoblastic Leukemia
Enrollment	154 participants
Start Date	2025-10-01
Primary Completion	2026-12-01 (estimated)
Study Completion	2026-12-30 (estimated)
Updated on ClinicalTrials.gov	2025-10-02